Abbvie CDR (Cad Hedged) (ABBV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 45,804,000 | 33,266,000 | 32,753,000 | 28,216,000 | 25,638,000 |
| Cost of Goods | 15,387,000 | 7,439,000 | 7,718,000 | 7,040,000 | 5,833,000 |
| Gross Profit | 30,417,000 | 25,827,000 | 25,035,000 | 21,176,000 | 19,805,000 |
| Operating Expenses | 19,054,000 | 12,844,000 | 18,652,000 | 11,584,000 | 10,421,000 |
| Operating Income | 11,363,000 | 12,983,000 | 6,383,000 | 9,592,000 | 9,384,000 |
| Interest Expense | 2,454,000 | 1,784,000 | 1,348,000 | 1,150,000 | 1,047,000 |
| Other Income | -5,511,000 | -2,773,000 | 162,000 | -715,000 | -453,000 |
| Pre-tax Income | 3,398,000 | 8,426,000 | 5,197,000 | 7,727,000 | 7,884,000 |
| Income Tax | -1,224,000 | 544,000 | -490,000 | 2,418,000 | 1,931,000 |
| Net Income Continuous | 4,622,000 | 7,882,000 | 5,687,000 | 5,309,000 | 5,953,000 |
| Minority Interests | -6,000 | N/A | N/A | N/A | N/A |
| Net Income | $4,616,000 | $7,882,000 | $5,687,000 | $5,309,000 | $5,953,000 |
| EPS Basic Total Ops | 0.29 | 0.56 | 0.39 | 0.35 | 0.39 |
| EPS Basic Continuous Ops | 0.29 | 0.56 | 0.39 | 0.35 | 0.39 |
| EPS Diluted Total Ops | 0.29 | 0.56 | 0.39 | 0.35 | 0.38 |
| EPS Diluted Continuous Ops | 0.29 | 0.56 | 0.39 | 0.35 | 0.38 |
| EBITDA(a) | $12,323,000 | $12,227,000 | $8,310,000 | $10,378,000 | $10,120,000 |